Figure 3From: Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkineCell cycle. The percentage of cells at G0/G1-, S- and G2/M-phases are plotted (%). Nos, noscapine; IM, imatinib mesylate; Nos+IM, noscapine with imatinib mesylate. Results are the mean of three different experiments and presented as mean ± SEM.Back to article page